How should we price across indications
The divergence in event rates between treatment groups observed within 1 year across both randomized trials and equally in our analyses suggests that meaningful effects may emerge within a short time frame
Based on the evidence, the FDA has concluded that this is not the case, reducing the risks of taking GLP-1 receptor agonists for people with preexisting depression
As a result, cysteinyldopa synthesis is induced, leading to increased production of pheomelanin, which is yellow-red
Patients interested in checking their insurance coverage can use Ro's GLP-1 Insurance Checker -- a free tool that has helped over 2 million people understand their benefits and get their medication at the lowest possible price whether that's using insurance coverage or paying cash
They work on entirely different things, so a direct comparison is tricky